Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited (SPi) has been marketing business and market research reports from selected publishers for over five years. SPi offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, SPi is well positioned to coordinate our customers' orders sourced from over 30 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1305 753769 or Email: office@sectorpublishing.com 2
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as clinical research and research support services. Vanderbilt s research support services includes study organization, IRB navigation, training, protocol development, preparation of study related documents, funding and contractual agreements and overall program advisory. The university offers its services through blair school of music, divinity school, school of engineering, law school, graduate school, school of medicine, and others. Vanderbilt is headquartered in Nashville, Tennessee, the US. Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy 3
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH63465D Number of Pages : 39 Report Format : PDF Publisher Information : A leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. 4
Table Of Contents for Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Vanderbilt University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Vanderbilt University, Medical Devices Deals, 2010 to YTD 2016 9 Vanderbilt University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 Vanderbilt University, Pharmaceuticals & Healthcare, Deal Details 12 Partnerships 12 Illumina Enters into Agreement with Vanderbilt University 12 Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 13 MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement 14 BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram 15 Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16 Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug 17 Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 19 Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson s Disease 20 Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 22 Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University 24 Licensing Agreements 25 La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 25 AstraZeneca Enters into Licensing Agreement with Vanderbilt University 26 AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery 27 Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology 28 Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization 30 Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma 31 Asset Transactions 32 Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University 32 Acquisition 34 Vanderbilt University Sells Microarrays 34 Vanderbilt University - Key Competitors 35 Key Employees 36 Locations And Subsidiaries 37 Head Office 37 Other Locations & Subsidiaries 37 Appendix 39 Methodology 39 5
About GlobalData 39 Contact Us 39 Disclaimer 39 6
List Of Tables in Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Vanderbilt University, Pharmaceuticals & Healthcare, Key Facts, 2015 1 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Vanderbilt University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Vanderbilt University, Deals By Therapy Area, 2010 to YTD 2016 8 Vanderbilt University, Medical Devices Deals, 2010 to YTD 2016 9 Vanderbilt University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 Illumina Enters into Agreement with Vanderbilt University 12 Diatherix Labs Enters into Research Agreement with Vanderbilt University Medical Center 13 MedImmune, GlaxoSmithKline and Vanderbilt University Enter into Agreement 14 BioReference Labs Enters into Co-Development Agreement with Vanderbilt-Ingram 15 Incyte Enters into Research Agreement with Vanderbilt University Medical Center 16 Vanderbilt University Enters Into Research Agreement With GlaxoSmithKline For Obesity Drug 17 Baptist Memorial Health Care Enters Into Research Agreement With Vanderbilt University 19 Vanderbilt University Enters Into Agreement With Bristol-Myers Squibb To Develop Drugs For Parkinson s Disease 20 Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 22 Seaside Therapeutics Enters Into Research Collaboration With Vanderbilt University 24 La Jolla Pharma Enters into Licensing Agreement with Vanderbilt University 25 AstraZeneca Enters into Licensing Agreement with Vanderbilt University 26 AstraZeneca Enters Into Licensing Agreement With Vanderbilt University For Neuroscience Drug Discovery 27 Parker Hannifin Enters Into Licensing Agreement With Vanderbilt University For Exoskeleton Technology 28 Nanoferix Enters into Licensing Agreement with Vanderbilt University Center for Technology Transfer and Commercialization 30 Vanderbilt University Enters Into Licensing Agreement With Karuna Pharma 31 Cumberland Pharma Acquires Rights Of Ifetroban From Vanderbilt University 32 Vanderbilt University Sells Microarrays 34 Vanderbilt University, Key Competitors 35 Vanderbilt University, Key Employees 36 Vanderbilt University, Subsidiaries 37 7
List Of Figures, Charts and Diagrams in Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Vanderbilt University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Vanderbilt University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Vanderbilt University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Vanderbilt University, Medical Devices Deals, 2010 to YTD 2016 9 8
How to Buy... Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at office@sectorpublishing.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Global License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1305 753769 We will be delighted to give you our personal attention. 9